Iyad Sultan
Overview
Explore the profile of Iyad Sultan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
2271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hassouneh D, Zatarah R, AbuSara A, Nazer L, Abu Ghosh A, Aryan H, et al.
Cancer Rep (Hoboken)
. 2025 Mar;
8(3):e70132.
PMID: 40065500
Introduction: Infections impact morbidity and mortality in pediatric cancer patients, yet limited studies have assessed the microbiological profiles and susceptibility patterns of pathogenic bacteria in this population. This study aimed...
2.
Qaddoumi A, Sultan Y, Wahbe A, Zayed N, Zaatreh M, Alani R, et al.
Ophthalmic Epidemiol
. 2025 Feb;
:1-10.
PMID: 39968750
Purpose: This study analyzes the prevalence, causes, and distribution of blindness and moderate-to-severe vision impairment (MSVI) in the Middle East and North Africa (MENA) using the Global Burden of Disease...
3.
Altalla B, Ahmad A, Bitar L, Al-Bssol M, Omari A, Sultan I
Int J Biomed Imaging
. 2025 Feb;
2025:5019035.
PMID: 39968311
Recent advancements in large language models (LLMs), particularly GPT-3.5 and GPT-4, have sparked significant interest in their application within the medical field. This research offers a detailed comparative analysis of...
4.
Aldalati A, Hussein A, Balbaa E, Hammadeh B, Idrees M, Aloudat O, et al.
Transpl Infect Dis
. 2025 Feb;
:e70006.
PMID: 39964143
Objective: Letermovir (LTV) is a novel antiviral agent approved by the FDA in 2017 for CMV prophylaxis in adult CMV-seropositive allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients and approved for...
5.
Altalla B, Abdalla S, Altamimi A, Bitar L, Omari A, Kardan R, et al.
Sci Rep
. 2025 Jan;
15(1):3852.
PMID: 39890969
The rapid digitalization of healthcare has created a pressing need for solutions that manage clinical data securely while ensuring patient privacy. This study evaluates the capabilities of GPT-3.5 and GPT-4...
6.
Sultan I, Alfaar A, Sultan Y, Salman Z, Qaddoumi I
PLoS One
. 2025 Jan;
20(1):e0314592.
PMID: 39752445
Background: The SEER Registry contains U.S. cancer statistics. To assess trends in incidence and survival and the impact of demographic factors among pediatric patients with cancer, we assessed nearly 5...
7.
Hashem H, Ghatasheh L, Najjar R, Mufarrej D, Zandaki D, Abu Shanap M, et al.
J Clin Immunol
. 2024 Dec;
45(1):59.
PMID: 39729175
Inborn errors of immunity (IEI) are a heterogenous group of rare monogenic disorders that affect innate or adaptive immunity, resulting in susceptibility to life-threatening infections and autoimmunity. Allogeneic hematopoietic cell...
8.
Yousef Y, Mohammad M, Baqain L, Al-Hussaini M, Abu Shanap M, Halalsheh H, et al.
Front Med (Lausanne)
. 2024 Sep;
11:1406215.
PMID: 39234041
Purpose: Retinoblastoma, a childhood cancer originating in the retina, is primarily attributed to pathogenic RB1 mutations The aim of this study is to conduct a mutational analysis of the RB1...
9.
Al-Nassan A, Almanaseer T, Malkawi S, Al-Bitar F, Jibrin D, El-Qurnah O, et al.
J Pediatr Hematol Oncol
. 2024 Aug;
46(7):e508-e514.
PMID: 39141785
Background: This study aimed to evaluate the factors associated with diagnosis delay in children with cancer who are treated at a single institution, which caters to most children with cancer...
10.
Al-Okaily A, Abu Khashabeh R, Alsmadi O, Ahmad Y, Sultan I, Tbakhi A, et al.
J Immunol Methods
. 2024 Jun;
531:113713.
PMID: 38925438
MHC class I pathway consists of four main steps: proteasomal cleavage in the cytosol in which precursor proteins are cleaved into smaller peptides, which are then transported into the endoplasmic...